Definium Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Definium Therapeutics, Inc. (DFTX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $527.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2024-02-28
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $527.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $3.16M.
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.37M.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $3.16M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2023-12-31 | $527.00K 10-K · filed 2024-02-28 |
| 2022-12-31 | $3.16M 10-K · filed 2023-03-09 |
| 2022-09-30 | $2.37M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.16M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.13M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.13M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |